Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H12O2 |
Molecular Weight | 164.2011 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CCCC1=CC=CC=C1
InChI
InChIKey=OBKXEAXTFZPCHS-UHFFFAOYSA-N
InChI=1S/C10H12O2/c11-10(12)8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H,11,12)
Molecular Formula | C10H12O2 |
Molecular Weight | 164.2011 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:37:56 UTC 2023
by
admin
on
Fri Dec 15 16:37:56 UTC 2023
|
Record UNII |
7WY7YBI87E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
126199
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
||
|
NDF-RT |
N0000175806
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
||
|
NDF-RT |
N0000175807
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
||
|
NCI_THESAURUS |
C1946
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID2037631
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
8480
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
DB06819
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
81647
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
ALTERNATIVE | |||
|
100000153321
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
C63699
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
24
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
C075773
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
295
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
7WY7YBI87E
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
41500
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
217-341-8
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
1546447
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
4775
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
1821-12-1
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
7WY7YBI87E
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY | |||
|
SUB127264
Created by
admin on Fri Dec 15 16:37:56 UTC 2023 , Edited by admin on Fri Dec 15 16:37:56 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE ACTIVE -> PRODRUG |
The active molecule that combines with glutamine (an amino acid with two nitrogen molecules) to form phenylacetylglutamine which is rapidly excreted by the kidneys and does not require metabolism via the urea cycle. Phenylbutyrate thus provides an “ammonia sink”, an alternative pathway for excretion of excess nitrogen and ammonia. The active metabolite phenylacetate is also effective therapeutically, but has a disagreeable odor and taste that affect compliance and acceptability.
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE -> PARENT |
EXCRETED IN URINE REMOVES AMMONIA FROM BODY
URINE
|
||
|
METABOLITE -> PARENT |
Formed in the liver and excreted in the urine responsible for the reduction of ammonia in the blood.
MAJOR
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|